Microbial Genomics Experts analyze the genetic makeup of microorganisms to unlock insights into their functions, adaptations, and interactions, particularly within the human gut microbiome. Using advanced techniques like whole-genome sequencing, metagenomics, and bioinformatics, they identify genes that enable probiotic strains to survive digestion, adhere to intestinal walls, and produce health-promoting compounds. Their research helps reveal how prebiotics influence microbial gene expression and community dynamics, improving our understanding of how to enhance gut health and prevent disease.
These experts also assess safety by screening microbial genomes for antibiotic resistance and harmful traits. Their findings guide the development of targeted probiotics and synbiotics tailored to individual microbiomes, paving the way for personalized nutrition and therapies. Collaborating with microbiologists, clinicians, and product developers, Microbial Genomics Experts bridge genetic research with practical health applications. As microbiome science advances rapidly, their work is crucial in translating genomic data into innovative solutions that support digestive health, immunity, and overall well-being. They contribute to large-scale microbiome mapping projects that deepen knowledge of microbial diversity. Their work also informs the design of next-generation probiotics with enhanced functionality. Moreover, they help identify biomarkers for disease risk and treatment response. By integrating genomics with systems biology, they enable holistic approaches to microbiome health. Their expertise is central to unlocking the full therapeutic potential of beneficial microbes.
Title : Results from a cross-sectional observational study examining irritable bowel syndrome patients six months after finishing their participation in the ViIBS trial
Jacek Piatek, Calisia University, Poland
Title : Gut microbiome as a driver of healthy ageing
Thi Thu Hao Van, RMIT University, Australia
Title : Treating irritable bowel syndrome patients with a balanced multi-strain synbiotic–results from a multi-center, randomized, double-blind, placebo-controlled clinical trial (the ViIBS trial)
Henning Sommermeyer, Calisia University, Poland
Title : Molecular mechanisms underlying the anti-atherogenic actions of probiotics
Dipak P Ramji, Cardiff University, United Kingdom
Title : Global regulatory trends on the use of probiotics and prebiotics in foods and food supplements
David Pineda Ereno, DPE International Consulting, Belgium
Title : Biochemical profile and nutripotential glimpses of Terminalia arjuna bark extract
Suriyavathana Muthukrishnan, Periyar University, India